The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Surgical staging and its prognostic impact on patients with borderline ovarian tumors (BOT): A subanalysis of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) ROBOT study.
Fabian Trillsch
No relevant relationships to disclose
Sven Mahner
No relevant relationships to disclose
Linn Lena Woelber
No relevant relationships to disclose
Eik Vettorazzi
No relevant relationships to disclose
Alexander Reuss
No relevant relationships to disclose
Nina Ewald-Riegler
No relevant relationships to disclose
Nikolaus De Gregorio
No relevant relationships to disclose
Christina Fotopoulou
No relevant relationships to disclose
Barbara Schmalfeldt
No relevant relationships to disclose
Alexander Burges
No relevant relationships to disclose
Felix Hilpert
No relevant relationships to disclose
Tanja N. Fehm
No relevant relationships to disclose
Werner Meier
No relevant relationships to disclose
Peter Hillemanns
No relevant relationships to disclose
Lars Christian Hanker
No relevant relationships to disclose
Annette Hasenburg
No relevant relationships to disclose
Hans-Georg Strauss
No relevant relationships to disclose
Martin Hellriegel
No relevant relationships to disclose
Pauline Wimberger
No relevant relationships to disclose
Andreas Du Bois
No relevant relationships to disclose